Rajesh Malik G1 Therapeutics, Inc. (GTHX) insider trading activity

GTHX Quotes by TradingView

Rajesh Malik is Chief Medical Officer of G1 Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GTHX, which is worth approximately $0. The most recent transaction as insider was on Apr 22, 2021, when has been sold 15,000 shares (Common Stock) at a price of $22.07 per share, resulting in proceeds of $331,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Rajesh Malik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 22 2021
SELL
Open market or private sale
$331,050 $22.07 p/Share
15,000 Reduced 25.73%
43,300 Common Stock
Apr 22 2021
BUY
Exercise of conversion of derivative security
$5,850 $0.39 p/Share
15,000 Added 20.46%
58,300 Common Stock
Mar 23 2021
SELL
Open market or private sale
$329,100 $21.94 p/Share
15,000 Reduced 25.73%
43,300 Common Stock
Mar 23 2021
BUY
Exercise of conversion of derivative security
$5,850 $0.39 p/Share
15,000 Added 20.46%
58,300 Common Stock
Mar 02 2021
SELL
Open market or private sale
$344,250 $22.95 p/Share
15,000 Reduced 25.73%
43,300 Common Stock
Mar 02 2021
BUY
Exercise of conversion of derivative security
$34,200 $2.28 p/Share
15,000 Added 20.46%
58,300 Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$1,209 $0.39 p/Share
3,100 Added 6.68%
43,300 Common Stock
Jan 22 2021
SELL
Open market or private sale
$309,600 $20.64 p/Share
15,000 Reduced 27.17%
40,200 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$62,550 $4.17 p/Share
15,000 Added 21.37%
55,200 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 21.48%
40,200 Common Stock
Dec 10 2020
SELL
Open market or private sale
$180,540 $20.06 p/Share
9,000 Reduced 23.56%
29,200 Common Stock
Dec 10 2020
BUY
Exercise of conversion of derivative security
$37,530 $4.17 p/Share
9,000 Added 19.07%
38,200 Common Stock

Also insider at

PNT
POINT Biopharma Global Inc. Healthcare
Director
RM

Rajesh Malik

Chief Medical Officer
Research Triangle Park, NC

Track Institutional and Insider Activities on GTHX

Follow G1 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GTHX shares.

Notify only if

Insider Trading

Get notified when an G1 Therapeutics, Inc. insider buys or sells GTHX shares.

Notify only if

News

Receive news related to G1 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GTHX